Related
- Video Game Design Reaches New Heights in 'Skyscraper Games'
- Drexel Researchers Gain New Insights from Malaria-Causing Parasite That May Support Development of Future Antimalarial Drugs
- Autism Researchers Explore Role of Environmental Influences on Autism as Part of Multi-Million Dollar NIH Effort
- MXene Current Collectors Could Reduce Size, Improve Recyclability of Li-Ion Batteries
What: David Elkins, vice president and chief financial officer of AstraZeneca North America and a 1995 graduate of Drexel University LeBow College of Business MBA program, will address what differentiating factors make the pharmaceutical industry a career industry of choice.In addition, Elkins will provide an overview of the career options available in pharmaceuticals and discuss the current challenges and opportunities surrounding the industry as well as its future. When: Wednesday, May 21, from 6 to 7:30 p.m. Where: Drexel's Pearlstein Business Learning Center (32nd and Market Streets)Background: David Elkins is a member of AstraZeneca’s U.S. Leadership Team and has responsibility for all finance, information technology and investor relations matters in North America. He is also a member of the board of directors for MedImmune Inc., a subsidiary of AstraZeneca. His experience outside of AstraZeneca includes Sr. Director of Corporate Strategy and Development at Unisys where he led the business development function. Elkins began his career at The Boeing Company.News Media Contact: Richard Barnes, assistant director of communications, Drexel's LeBow College of Business 215-895-2075 or richardb@drexel.edu Niki Gianakaris, assistant director, Drexel News Bureau 215-895-6741, 215-778-7752 (cell) or ngianakaris@drexel.edu